Why isn't this info up on the website?

what is mammoprint, I have never heard this word before?

MsBliss probably because it is such a new procedure not much is known about it....

Hi MsBliss

  Understand that with mammaprint you would get an "opinion" on what your risk of recurrence for 5-7 years is. The testing has become accepted in some European countries but not yet widely accepted in North America. I would hazard a guess that most onc's when treating triple - would not base adjuvant decisions solely on mp, or, in other words, simply because you came back with a lower risk decide not to do chemo solely for that reason. I personally wouldnt feel comfortable with an aggressive BC disregarding the standard treatments because my tumour "seems" to indicate that it might fall within the category of "not likely" to recurr. Might this test and others be a bigger part of the decison tree in the future...sure they will...but until there are long term follow ups with those who perhaps in other countries choose to avoid chemo because of MP imho I dont think the Dr.'s here are going to be jumping on the bandwagon in totality just yet. Remember that when you are dealing with triple neg you are dealing with a variety of tumours that are still very unpredicatable even with mp. For those who are interested ...here is a link to an article from last year which references the increasing use of MP by the Dutch goverment in their health care system and also in simple terms explains MP

http://www.medicalnewstoday.com/articles/122036.php

and a further article from Dr. Susan Love where both the upside and pitfalls of this testing is discussed

http://www.dslrf.org/endingbc/content.asp?L2=3&L3=5&SID=130&CID=1317&PID=20&CATID=0

Hope this helps !

That's Adjuvant Online deb6563.

I'm not TN, but since TN is known for its aggresivness, I highly doubt that any onc would rely on any "test" to decide treatment. And since, there is no targeted therapies available yet... TN needs to be treated aggressivly , meaning surgery chemo and rads.

Sounds like you onc is "on the ball". TN has better response to Dose dense chemo regime as well. I look at everything this way, no matter how aggresive my BC was, I would do anything to treat it. If I had to drink bleach to get rid of it I would. I find it very unsettling that some woman rely on a "test" when it comes to their treatment. Ummmm... bonjour..this is cancer!!! JMO

MsBliss:

Hi, i am new to this forum and feel i might be able to shed some light on the MammaPrint questions.  For full disclosure, I used to work with Agendia/MammaPrint, and my husband still does. 

MammaPrint is a second-generation multi-gene test for recurrence. They analyze about 1500 total genes, with a specific 70 to determine either a high risk or low risk without the intermediate score.  Many women don't know much about it as it has only been offered in the US for about a year now.  Many Onc's may not know much about it as it is ordered by your surgeon, and the test is run on fresh tumor sample.  That means the tissue has to be taken at either initial bx, lumpectomy, or mastectomy.

Without trying to sound like a advertisement, some of the differences of mammaprint are that it is the only FDA-cleared/multi-gene assay. (no oncotype is not) It is indicated for both ER- & ER+ BC.  I was just told that it has just been approved for up to 3+ nodes as well.  The dominant test is the OncotypeDx.  The oncologist can order it and it is easier to order as they can analyse samples using parafin blocks.  You can research both companies at www.agendia.com and www.genomichealth.com

Hope this helps.